GrowingStockReport.com

NASDAQ Gainers Watch List: OXiGENE, Inc. (NASDAQ:OXGN) and BioLineRx, Ltd. (NASDAQ:BLRX) Added to Growing Stock Report's NASDAQ Gainers Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 04/10/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding OXiGENE, Inc. (NASDAQ:OXGN) and BioLineRx, Ltd. (NASDAQ:BLRX).

OXiGENE, Inc. (NASDAQ:OXGN) a clinical-stage biopharmaceutical company that develops therapeutics to treat cancer and eye diseases is currently up (+27.22%) on 502,876 shares traded after OXIGENE INC Filed SEC form 8-K, Other Events. OXiGENE, Inc. (NASDAQ:OXGN) is currently up (+46.45%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about OXiGENE, Inc. (NASDAQ:OXGN)

BioLineRx, Ltd. (NASDAQ:BLRX) a clinical stage biopharmaceutical development company that engages in identifying, in-licensing, and developing therapeutic candidates is currently up (+16.38%) on 914,162 shares traded after BioLineRx Received Regulatory Approval to Commence Phase II Clinical Trial for BL-8040, for Treatment of Leukemia. BioLineRx, Ltd. (NASDAQ:BLRX) is currently up (+32.08%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about BioLineRx, Ltd. (NASDAQ:BLRX)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com